Table 1

Predictors of 30-day mortality in 50 cirrhotic patients at SARS-CoV-2 diagnosis

Baseline variables	Category	Univariate analysis*		Multivariate analysis
Baseline variables	Category	OR (95% CI)	P value	OR (95% CI)	P value
Creatinine, mg/dL	Continuous	2.80 (1.10 to 7.13)	0.031
CPT score	A vs B/C	0.20 (0.04 to 0.83)	0.027
MELD	Continuous	1.15 (1.03 to 1.29)	0.009
CLIF-OF	Continuous	1.74 (1.24 to 2.44)	0.001	2.12 (1.23 to 3.65)	0.006
Lung failure†	Moderate/severe vs absent/mild	1.82 (1.08 to 3.06)	0.022
CCI	Continuous	2.91 (1.55 to 5.53)	0.001	4.93 (1.46 to 16.60)	0.010

Logistic regression analysis was used to identify factors associated with 30-day mortality and used a significance level of 0.05.
*Variables included in univariate analysis but not significantly associated to 30-day mortality: age, sex, bilirubin, albumin, aetiology of liver disease, diabetes mellitus, comorbidities, smoking history, hepatocellular carcinoma history.
†Moderate/severe lung failure PaO₂/FiO₂ ≤200 mm Hg.
CCI, Charlson Comorbidity Index; CLIF, European Foundation for the Study of Chronic Liver Failure Consortium; CPT, Child-Pugh-Turcotte; MELD, Model for End-Stage Liver Disease; OF, organ failure.